secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zura Bio Ltd (ZURA)
CIK:        0001855644
Form:       8-K
Filed at:   2023-06-02T23:59:59+00:00
Accession:  0001104659-23-067181
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zura Bio shareholders approve $64M private placement and equity plan expansion
------------------------------------------------------------------------------

- Issuance of 15,073,530 shares (including 3,782,000 pre-funded warrants) for ~$64M approved; closing June 5.
- Chairman Amit Munshi to receive 117,647 shares and options for 1,130,000 shares under Equity Compensation Proposal.
- Equity Incentive Plan increased by 5,564,315 shares to total 9,594,213 shares, plus annual 5% evergreen increase.
- Combined with $16M issued May 1, total placement exceeds 20% of outstanding shares at a discount to Nasdaq's Minimum Price.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855644/000110465923067181/0001104659-23-067181-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855644/000110465923067181/tm2317576d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-067181

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer